Treatment of idiopathic nonhistaminergic angioedema with bradykinin B2 receptor antagonist icatibant

Ann Allergy Asthma Immunol. 2012 Jun;108(6):460-1. doi: 10.1016/j.anai.2012.03.013. Epub 2012 Apr 10.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Angioedema / drug therapy*
  • Angioedema / immunology
  • Angioedema / metabolism
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Bradykinin / administration & dosage
  • Bradykinin / analogs & derivatives*
  • Bradykinin / metabolism
  • Bradykinin / therapeutic use
  • Bradykinin B2 Receptor Antagonists*
  • Humans
  • Injections, Subcutaneous
  • Male
  • Middle Aged
  • Receptor, Bradykinin B2 / metabolism

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Bradykinin B2 Receptor Antagonists
  • Receptor, Bradykinin B2
  • icatibant
  • Bradykinin